EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-8 and IL-1RA serum levels predicting depression treatment response in 6-week follow-up

Tuukka Mökkönen iD, Anssi Solismaa, Mari Hämäläinen, Eeva Moilanen, Olli Kampman iD

Acta Neuropsychiatrica · 2025

DOI: 10.1017/neu.2025.10027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropsychiatrica, 2025. Verfasst von Tuukka Mökkönen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland. Hauptthemen laut MEDLINE: Major Depressive Disorder, Interleukin-8, Interleukin 1 Receptor Antagonist Protein, Antidepressive Agents. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to ascertain the effect of baseline IL-1Ra and IL-8 in the treatment response of patients with major depressive disorder (MDD) and to clarify the relationship between inflammation markers and depression.

Methods

We recruited 242 patients with a Beck Depression Inventory (BDI) score ≥ 17 referred to secondary care in Finland. The patients’ serum IL-1Ra and IL-8 concentrations were measured at baseline. Montgomery-Åsberg Depression Rating Scale (MADRS) tests and Alcohol Use Disorders Identification Tests (AUDIT) were administered at baseline and six weeks. The antidepressant treatments varied: somewere started, others changed or continued their previous medication, and others had their doses adjusted. Patients started behavioral activation therapy. Linear regression was used with a relative MADRS score change during six weeks as the dependent variable and patient age, AUDIT score, BMI, daily number of cigarettes smoked, sex, and serum IL-1Ra and IL-8 concentrations as independent variables.

Results

Higher baseline serum IL-1Ra and IL-8 levels were associated with a smaller relative change in the MADRS-score within the first six weeks of treatment in linear regression analysis ( p < 0.001 and p = 0.007, respectively). In further analysis comparing groups with ≤ 24 and>24 MADRS score only the ≤ 24 MADRS score group showed a similar association.

Conclusion

Higher baseline IL-1Ra and IL-8 concentrations were associated with a lesser relative response to depression treatment, particularly in patients with mild depression. Results on IL-8 concur with earlier findings, whereas the association between higher IL-1Ra serum concentrations reduced treatment response is a novel finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderInterleukin-8Interleukin 1 Receptor Antagonist ProteinAntidepressive AgentsHumansMaleFemaleMiddle AgedAdultFollow-Up StudiesTreatment OutcomePsychiatric Status Rating ScalesFinlandBiomarkersAged

Stichwörter der Autor:innen

Interleukin-8depressionfollow-up studyinflammationinterleukin-1Ra

Substanzen

Interleukin-8Interleukin 1 Receptor Antagonist ProteinAntidepressive AgentsBiomarkersCXCL8 protein, human

Autor:innen und Institutionen

  • Department of Psychiatry, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.
  • Department of Psychiatry, The Pirkanmaa Wellbeing Services County, Tampere, Finland.
  • The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.
  • Department of Psychiatry, Department of Clinical Sciences (Psychiatry), Faculty of Medicine, University Hospital of Umeå, Umeå University, Umeå, Sweden.
  • Department of Clinical Medicine (Psychiatry), Faculty of Medicine, University of Turku, Turku, Finland.
  • Department of Psychiatry, The Wellbeing Services County of Ostrobothnia, Vaasa, Finland.

ORCID-Profile: Tuukka Mökkönen, Olli Kampman

Zitieren

APA

Mökkönen, T., Solismaa, A., Hämäläinen, M., Moilanen, E., & Kampman, O. (2025). IL-8 and IL-1RA serum levels predicting depression treatment response in 6-week follow-up. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2025.10027

Vancouver

Mökkönen T, Solismaa A, Hämäläinen M, Moilanen E, Kampman O. IL-8 and IL-1RA serum levels predicting depression treatment response in 6-week follow-up. Acta Neuropsychiatrica. 2025. doi:10.1017/neu.2025.10027

BibTeX
@article{Mkknen2025,
  author = {Mökkönen, Tuukka and Solismaa, Anssi and Hämäläinen, Mari and Moilanen, Eeva and Kampman, Olli},
  title = {IL-8 and IL-1RA serum levels predicting depression treatment response in 6-week follow-up},
  journal = {Acta Neuropsychiatrica},
  year = {2025},
  doi = {10.1017/neu.2025.10027}
}
Kostenlos starten →